focus -WSS

focus

author：Wikipedia 2025-09-28 01:37:08 - browse：75

Portrait of Robert Langer. -- biotech coverage from STAT. — Serial biotech entrepreneur Bob Langer will serve as an adviser to T.rx Capital. Pat Greenhouse/Globe Staff

Executives from the shuttered digital health company Pear Therapeutics are launching a new VC firm, offering early access to new startups formed by serial biotech entrepreneur Bob Langer.

Former Pear CEO Corey McCann and former licensing head Michael Langer formed the new firm, T.rx Capital, earlier this year, according to three people with knowledge of the firm and documents reviewed by STAT. Michael Langer, the son of Bob Langer, confirmed the news and that they had set a $175 million cap for its first fund.

The firm will invest in therapeutics and digital health products by both forming new companies and taking pitches from early-stage startups. T.rx has brought in Everly Health executive Liz Kwo and Caris Life Sciences vice president Debbie Lin as venture partners, while current Eli Lilly business development team member Kwesi Frimpong-Boateng will be joining T.rx’s founding team. Bob Langer is a scientific adviser.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Health tech investors get more selective as pandemic boom fades

WSS

Is there really a nursing shortage in the U.S.?

CommonSpirit Health keeps growing, even as it loses money

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

ADCs take center stage as promising cancer treatments

FDA panel to weigh approval of NurOwn, controversial ALS drug

UnitedHealth, Optum discontinue NaviHealth name

Wikipedia

focus

knowledge

Anesthesiologist group: stop taking Ozempic before surgery

Biotech lab space demand falls sharply

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Results on Novartis prostate cancer therapy could expand its use

Anesthesiologist group: stop taking Ozempic before surgery

Readout LOUD podcast: possible new ALS drug, artificial wombs

In Memoriam: Notable people who died in 2023

Results on Novartis prostate cancer therapy could expand its use

Trump demands the U.S. pay no more for drugs than other countries … again

STAT Readout: Friday, Oct. 20 biotech updates

Wikipedia

ADCs take center stage as promising cancer treatments

What Congress can do to address the rural doctor shortage

How Vertex's cystic fibrosis drug is changing patients' lives

Health tech investors get more selective as pandemic boom fades

Ukraine and a new approach to mental health in war

EpiPen alternative approval delay highlights citizen petition issue

explore

Wikipedia

Wikipedia

leisure time